Overview
Bioptimus is a pioneering biomedical AI company dedicated to building the first universal AI foundation models for biology. By breaking down current data silos, Bioptimus integrates multi-modal, multi-scale biological information into a single, comprehensive body of knowledge. Their flagship models include M-Optimus, a world model for biology, and H-Optimus-1, currently the leading foundation model for histology. Trained on over 2 billion images and backed by $76 million in funding, Bioptimus models have seen widespread adoption with over 1 million downloads and utilization in more than 100 scientific publications annually. The platform empowers researchers, clinicians, and biopharma companies to transform clinical trials, predict patient outcomes like progression-free survival and breast cancer recurrence, and streamline spatial transcriptomics workflows. Built in Paris by a world-class team of machine learning engineers and biological data scientists, Bioptimus leverages secure, scalable, state-of-the-art GPU computing to accelerate biomedical innovations and environmental science breakthroughs.